The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
MTD · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | CPRX | HRMY | MTD | REGN |
|---|---|---|---|---|
| Moat Score (0–100) | 82 (highest) | 82 (highest) | 82 (highest) | 81 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 95 (highest) | 95 (highest) | 72 | 29 |
| Pricing power | 100 (highest) | 99 | 97 | 100 (highest) |
| Returns on capital | 88 | 100 (highest) | — | 97 |
| Balance-sheet safety | 100 (highest) | 86 | 67 | 100 (highest) |
| Capital allocation | 24 | 32 | 91 (highest) | 80 |
| 234% above value if growth stopped today | 16% above value if growth stopped today (largest discount to value if growth stopped today) | 242% above value if growth stopped today | No price data | |
| Market cap | $3.9B | $2.2B | $32.8B | Not reported |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |